12,081
Total Claims
$588K
Drug Cost
703
Beneficiaries
$837
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-41%
Cost per patient vs peers
$837 vs $1,411 avg
-30%
Brand preference vs peers
7.4% vs 10.6% avg
Brand vs Generic
93% generic
Brand: 895 claims · $400K
Generic: 11,138 claims · $188K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 118 | $128K |
| Apixaban | 156 | $111K |
| Rivaroxaban | 59 | $39K |
| Atorvastatin Calcium | 1,501 | $24K |
| Budesonide/Formoterol Fumarate | 37 | $17K |
| Metoprolol Succinate | 460 | $11K |
| Levothyroxine Sodium | 550 | $10K |
| Lisinopril | 753 | $8,844 |
| Losartan Potassium | 472 | $7,524 |
| Rosuvastatin Calcium | 187 | $6,616 |
| Tiotropium Bromide | 11 | $6,486 |
| Amlodipine Besylate | 579 | $6,208 |
| Omeprazole | 399 | $6,181 |
| Albuterol Sulfate | 150 | $5,985 |
| Dexlansoprazole | 12 | $5,106 |
Prescribing Profile
105
Unique Drugs
$278K
Patient Profile
75
Avg Age
49%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About